"Pathogenic" Launches on Steam, Lets Players Invade the Human Body as a Pathogen
The game's demo earned an "Overwhelmingly Positive" rating on Steam, a strong indicator of player reception for its unique pathogen-themed roguelike gameplay.
Key Facts
- "Pathogenic" launched on Steam on July 16, 2026.
- The game is a 2D roguelike shooter developed by Aberrant Labs and published by Slug Disco.
- Players choose from seven initial parasites and combine over 120 organelles and mutations.
- The demo received an "Overwhelmingly Positive" rating on Steam and was played by over 110,000 people.
- The launch price is 1,000 yen, with a 20% discount to 800 yen until July 31.
Reporting from 2 sources: 4Gamer.net, Denfaminicogamer.
Slug Disco and Aberrant Labs released the roguelike shooter "Pathogenic" on Steam on July 16, 2026. The game casts players as a pathogen that has invaded a human body, tasking them with fighting the immune system, rival parasites, and protozoa to achieve complete control of the host. Players choose from seven initial parasites and can collect and combine over 120 types of organelles and mutations to create powerful builds. The in-body stages are six randomly generated organ environments, from the intestines to the heart. Permanent upgrades are unlocked by collecting plasmid fragments. A 20% launch discount brings the price to 800 yen (tax included) until July 31. The game's demo, played by over 110,000 people, earned an "Overwhelmingly Positive" rating on Steam, and the title accumulated over 100,000 wishlist additions before release. "Pathogenic" supports Japanese and is available for PC and Mac.
The six organ stages in "Pathogenic" are randomly generated and include environments such as the winding intestines and the beating heart, each with distinct characteristics. Players face immune cells like macrophages and T cells, as well as rival parasites. After defeating the final boss, hidden stages and 15 types of challenge modes become available. The game is developed by indie studio Aberrant Labs and published by Slug Disco, known for previous simulation titles. The launch price is 1,000 yen, with a 20% discount reducing it to 800 yen until July 31. The demo's success-over 110,000 players and an "Overwhelmingly Positive" rating-helped drive more than 100,000 wishlist additions before release. The game also includes Japanese language support. Players can permanently upgrade their pathogen by collecting plasmid fragments, unlocking new pathogens and enhancements across runs.
Synthesized by Yomimono from the 2 cited sources below, including Japanese-language reporting where cited, then editorially reviewed before publishing.